HistaPharma

Poland
Piecki, Warmia-Masuria, Poland, 62-002

Company profile

HistaPharma company profile

HistaPharma is a developer of advanced pharmaceutical products designed to treat respiratory diseases and allergies affecting both the respiratory system and skin. The company's product portfolio includes medications used in the management of asthma, chronic obstructive pulmonary disease (COPD), allergic rhinitis, and skin allergies, such as chronic urticaria. By offering effective therapeutic solutions, HistaPharma enables healthcare professionals to improve patient outcomes within the desired time frame.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Founded
2018-01-01, Year

Headquarters

Postal code
62-002
Country code
PL
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$489,762
Last funding
Pre Seed / $489,762 / 2018-04-27
Last equity funding
Pre Seed / $489,762
Investors
1

Founders and investors

Investors

YouNick Mint